1 BTC
=
- USD
Enveric Biosciences, Inc. Common Stock
As of May 30, 2026 at 24:05 UTC
Chart
About Enveric Biosciences, Inc. Common Stock
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
Market Statistics
Trading Metrics
How to Buy ENVB
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy ENVB
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesEnveric Biosciences (NASDAQ: ENVB) surged over 106% in premarket trading following President Trump's executive order directing federal agencies to accelerate approval timelines for psychedelic-based treatments. The administration also committed $50 million to ibogaine research. While momentum is improving with positive MACD signals, the stock remains 47.2% below its 200-day moving average, indicating the rally occurs within a longer-term downtrend.
The latest trading day saw Enveric Biosciences, Inc. (ENVB) settling at $0.93, representing a -0.46% change from its previous close.
Enveric Biosciences, Inc. (ENVB) closed the most recent trading day at $0.90, moving -0.56% from the previous trading session.
